ABBV AbbVie Inc.
$293.89
AbbVie Inc. (ABBV) Earnings News
Earnings press releases, previews and reviews for AbbVie Inc. (ABBV), newest first. Our most recent is review: AbbVie Beats and Effectively Absorbs Its IPR&D Charge, but Skyrizi's Slowdown Tests a Stock Priced at Its Highs.
Friday
October 30, 2026
2:22 PM ET
AbbVie Beats and Effectively Absorbs Its IPR&D Charge, but Skyrizi's Slowdown Tests a Stock Priced at Its Highs
Earnings Whispers · Review
Friday
October 30, 2026
7:46 AM ET
AbbVie Reports Third-Quarter 2026 Financial Results
Thursday
October 22, 2026
7:25 AM ET
AbbVie Faces a Street Forecast Above Its Own Guidance as Immunology Momentum Meets Apogee Dilution
Earnings Whispers · Preview
Thursday
October 1, 2026
8:00 AM ET
AbbVie to Host Third-Quarter 2026 Earnings Conference Call
Friday
July 31, 2026
7:47 AM ET
AbbVie Reports Second-Quarter 2026 Financial Results
Friday
June 26, 2026
8:00 AM ET
AbbVie to Host Second-Quarter 2026 Earnings Conference Call
Monday
June 22, 2026
7:00 AM ET
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio